Juvenescence and its partners – The Buck Institute for Research on Aging, Insilico Medicine, and LyGenesis – have been identified as leaders who are driving important scientific advances in the longevity field.
Longevity Technology evaluates the trajectories for many companies and scientists in the longevity space as a part of their Longevity Readiness Series. They acknowledge Juvenescence and its partners are designed to drive innovation in each key area of age-related research, as well as its strategic investments in innovative machine learning and artificial intelligence.
The Buck Institute for Research on Aging, Insilico Medicine, and LyGenesis are each acknowledged for their specialized contributions and research to longevity: the most advanced longevity research, acceleration of drug discovery and development through AI, and regeneration technology, respectively.
Read the full article at Longevity Technology.
